DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Network Meta-Analysis for Health Technology Submissions Worldwide: A Report Checklist for Best Practice

Network meta-analysis (NMA) is an accepted statistical method used to model the clinical- and cost-effectiveness of treatments in the absence of data from head-to-head randomised controlled trials (RCTs). In the fifth of our DRG investigative series, we assess submission guidelines by health technology assessment (HTA) bodies and suggest a reporting checklist for NMAs to support manufacturers in meeting the requirements for global technology appraisal.